Skip to main content
. 2020 Apr 24;4(6):nzaa078. doi: 10.1093/cdn/nzaa078

TABLE 2.

Study design factors to consider in diet-induced nonalcoholic fatty liver disease rodent models1

High-fat diets High-fructose diets High-fat, -fructose, and -cholesterol diets Choline-deficient high-fat diets Methionine- and choline-deficient diets
Dietary modifications commonly used
  • 30–60 kcal% fat, higher SFAs increase ER stress, higher ω-6 PUFAs increase increase oxidative stress, both increase NASH

  • More sucrose or fructose leads to NASH and mild fibrosis

  • Usually 60–70 kcal% fructose drives steatosis, NASH

  • The addition of sucrose (50%fructose) also effective effective for steatosis, NASH

  • 40 kcal% fat (trans fat or SFAs), 20–40 kcal% fructose, and 1–2% cholesterol

  • Fat type and cholesterol increase ER and oxidative stress/fibrosis

  • Fructose drives steatosis and inflammation

  • Fat amount (30–60 kcal% fat)

  • Lard commonly used; typically can drive steatosis, but prolonged feeding (6 mo) can cause fibrosis

  • Rapid onset of steatosis (1 wk), NASH/fibrosis in 6–8 wk

  • Addition of fat (≤60 kcal% fat)

  • Fat type typically lard, butter (SFAs), or corn oil (PUFAs), addition of sucrose and/or cholesterol drives further NASH/fibrosis

Other metabolic effects
  • Increases body weight

  • IR/glucose intolerance

  • Increases body weight

  • IR/glucose intolerance

  • Increased plasma TGs (typically ratsand hamsters)

  • Increases body weight

  • IR/glucose intolerance

  • Increases plasma lipids

  • Increases body weight

  • Less IR than choline-sufficient diet

  • Reduces body weight, but 0.1% methionine maintains weight

  • No IR, reduced plasma lipids

Matched control diet
  • Low-fat diet with matched amount of sucrose or mostly corn starch

  • Low-fat diet with 60–70 kcal% as either glucose or corn starch

  • Low-fat diet with 60–70 kcal% as either glucose or corn starch

  • Low-fat diet with choline

  • Methionine- and choline-sufficient diet

1ER, endoplasmic reticulum; IR, insulin resistance; NASH, nonalcoholic steatohepatitis; TG, triglyceride.